Form 4: Clene Inc. Director Alison Mosca Acquires Stock Options
SEC Form 4 Filing
Director Alison Mosca reports acquisition of stock options in Clene Inc.
Summary
- Alison Mosca, a director of Clene Inc., reported a transaction on October 2, 2024.
- Mosca acquired stock options for 3,902 shares of Clene Inc. common stock.
- The exercise price for these options is $4.89 per share.
- The options vest immediately upon grant and expire on October 1, 2034.
- Following the transaction, Mosca directly owns 3,902 derivative securities.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of stock option grants.
Positives
- The immediate vesting of the options could incentivize the director to work towards the company's success.
Industry Context
This is a standard SEC Form 4 filing, indicating a change in beneficial ownership by a company insider. Option grants are a common form of executive compensation in the biotechnology industry.
Stakeholder Impact
- The stock option grant could potentially align the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 10/02/2024 | Date of transaction: Alison Mosca acquired stock options. |
| 10/01/2034 | Expiration date of the stock options. |
| 10/03/2024 | Date of report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.